Mr. Stefan Eftychiou reports
NOTICE OF CIPHER PHARMACEUTICALS Q4 2018 CONFERENCE CALL
Cipher Pharmaceuticals Inc. has provided the details of its Q4 2018 financial results conference call on Tuesday, March 19, 2019. The call will be hosted by Robert Tessarolo, president and chief executive officer, and Stephen Lemieux, chief financial officer. The company will issue its financial results on the morning of March 19, 2019.
Conference call details
Date: Tuesday, March 19, 2019
Time: 8:30 a.m. EDT
Dial-in number: 416-764-8609 or 888-390-0605
Conference ID No.: 05671895
Replay: 888-390-0541 (playback code 671895)
(available until 12 a.m. EDT on March 26, 2019)
Webcast: The audio webcast can be accessed at the company's website under investor relations.
About Cipher Pharmaceuticals Inc.
Cipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early- to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America.
© 2019 Canjex Publishing Ltd. All rights reserved.